BOTTA, CIRINO
 Distribuzione geografica
Continente #
NA - Nord America 258
EU - Europa 136
AS - Asia 121
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
SA - Sud America 3
Totale 525
Nazione #
US - Stati Uniti d'America 249
SG - Singapore 103
IT - Italia 89
GB - Regno Unito 15
SE - Svezia 12
CA - Canada 7
CN - Cina 7
HK - Hong Kong 7
NL - Olanda 7
EU - Europa 4
CL - Cile 3
CZ - Repubblica Ceca 3
ES - Italia 3
IN - India 3
FI - Finlandia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PL - Polonia 2
AU - Australia 1
BY - Bielorussia 1
DE - Germania 1
PK - Pakistan 1
PT - Portogallo 1
Totale 525
Città #
Singapore 65
Chandler 47
Santa Clara 22
Milan 16
London 14
Princeton 13
Chicago 12
Lawrence 12
Ashburn 9
Catanzaro 8
Hong Kong 7
Ottawa 6
Boardman 5
Wilmington 5
Des Moines 4
Lamezia Terme 4
Redmond 4
Utrecht 4
Barcelona 3
Castrovillari 3
Naples 3
Redwood City 3
Rome 3
Rosarno 3
San Antonio 3
San Nicola Manfredi 3
Chennai 2
Cortale 2
Grottaglie 2
Helsinki 2
Leawood 2
Mexico City 2
Olomouc 2
Padova 2
Palermo 2
Santiago 2
Santo Stefano di Rogliano 2
Acri 1
Auckland 1
Bari 1
Catania 1
Clearwater 1
Crotone 1
Filadelfia 1
Guangzhou 1
Hanover 1
Kansas City 1
Lahore 1
Los Angeles 1
Mascalucia 1
Minsk 1
Norwalk 1
Oristano 1
Ovada 1
Parma 1
Phoenix 1
Rende 1
Roccella Jonica 1
Saint Louis 1
Settingiano 1
Shanghai 1
Sydney 1
The Dalles 1
Toronto 1
Trieste 1
Turin 1
Vancouver 1
Washington 1
Zevio 1
Totale 335
Nome #
miR-22 suppresses DNA ligase III addiction in multiple myeloma 73
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 47
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 44
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 41
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 39
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 32
Influence of the fabrication accuracy of hot-embossed PCL scaffolds on cell growths 30
Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma 30
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 28
Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response 26
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 26
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology 24
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 24
Iron-mediated oxidative stress induces PD-L1 expression via activation of c-Myc in lung adenocarcinoma 20
Elotuzumab plus Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials 19
Myositis/myasthenia after pembrolizumab in a bladder cancer patient with an autoimmunity-associated HLA: Immune–biological evaluation and case report 17
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma 15
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials 14
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials 14
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies 8
Totale 571
Categoria #
all - tutte 6.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206 0 0 0 0 0 0 0 0 0 0 0 6
2020/202149 4 0 3 2 1 7 2 5 12 10 3 0
2021/202267 0 0 1 11 7 2 7 9 8 9 13 0
2022/2023151 25 16 16 5 12 14 6 7 26 7 13 4
2023/2024104 24 13 5 18 9 19 0 0 3 2 2 9
2024/2025188 29 7 10 19 21 42 13 13 29 4 1 0
Totale 571